Hints and tips:
Related Special Reports
...AstraZeneca chief executive Pascal Soriot said last month that the company planned to build independent drug supply chains for the US and China....
...by an advisory committee of independent experts....
...Biogen discontinued the drug in January, capping a saga that drew criticism from two congressional committees and led to resignations by three independent experts from an FDA panel....
...Security co-operation between Mexico and the US, which share a 2,000-mile border, involves a web of agencies....
...committee of independent experts....
...“What we’re trying to do is give the liver a little nudge in the right direction to support it to regenerate,” said Quin Wills, chief scientific officer and co-founder of Ochre Bio....
...The company said the decision was partly driven by huge demand for weight-loss drugs....
...drugs....
...Simon Vanstone Independent Lifescience Consultant, London E14, UK...
...The UK anti-doping agency has joined calls for an independent review of how global sport’s anti-drugs body dealt with Chinese swimmers testing positive for a banned substance, as elite athletes gear up to...
...insurers to cover the drug....
...Zealand’s earlier drug candidates include a non-GLP-1 drug for obesity based on amylin that Steensberg said could reduce side effects such as nausea....
...It was closely connected with Silicon Valley royalty: Anne Wojcicki, the company’s co-founder and chief executive, received early backing from Sergey Brin, the co-founder of Google whom she went on to marry...
...Bobby Gaspar, co-founder and chief executive of Orchard, said Lenmeldy was “a paradigm-shifting medicine”, adding that the company was “committed to enabling broad, expedient and sustainable access to this...
...BSP and National Resilience are among a group of highly specialised contract manufacturers benefiting from the boom in obesity drugs....
...Scientists have invented a potential drug candidate that successfully combats antibiotic-resistant “superbugs” in non-human tests, according to research....
...According to the Health Transformation Alliance, a co-operative of American employers seeking cheaper healthcare, the use of anti-obesity drugs among its members was 64 per cent higher in 2023 than in 2022...
...“We aim to not just alleviate disease symptoms, but to address the root causes of heart failure and restore the normal functioning of the heart,” said Thomas Thum, Cardior’s co-founder....
...It is also unlikely that Eli Lilly will provide enough doses of the drug to Britain to meet the demand for weight loss treatments....
...“There’s a lot of biotech investors and big pharmaceutical companies sitting on the sidelines . . . they want to see what the commercial rollout looks like,” said Tim Schlidt, co-founder of Palo Santo, a...
...However, analysts argue that Bukele’s tactics — in which 76,000 suspected gang members have been locked up since March 2022 — would fail in Ecuador, where criminal groups are better funded and have co-opted...
...“So a big ask of this trip is to encourage independent action as well.”...
...For years, the argument was that overweight people didn’t need obesity drugs because diet and exercise worked....
...“I think the number of specific drugs we have in cancer and the way that patients are treated with different drugs at different stages of the disease will be the future for dementia.”...
...Lobritz is co-author with experts from Harvard University of the two papers published in Nature on Wednesday....
International Edition